Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth L. McClain, MD, PhD
Texas Children's Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital de Pediatria Garrahan
Buenos Aires, Buenos Aires, Argentina
- St. Anna Children'S Hospital
Vienna, Austria
- Hospital for Sick Children
Toronto, Ontario, Canada
- Chr Hotel Dieu
Nantes, France
- University Medical Center Hamburg - Eppendorf
Hamburg, Germany
- Our Lady'S Hospital for Sick Children Crumlin
Dublin, Ireland
- Fondazione I.R.C.C.S. Policlinico San Matteo
Pavia, Italy
- Karolinska University Hospital - Solna
Stockholm, Sweden
- Birmingham Children'S Hospital
Birmingham, England, United Kingdom
- Institute of Child Health at University of Bristol
Bristol, England, United Kingdom
- Addenbrooke'S Hospital
Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
- Children'S Cancer and Leukaemia Group
Leicester, England, United Kingdom
- Leicester Royal Infirmary
Leicester, England, United Kingdom
- Royal Liverpool Children'S Hospital, Alder Hey
Liverpool, England, United Kingdom
- Great Ormond Street Hospital for Children
London, England, United Kingdom
- Royal London Hospital
London, England, United Kingdom
- Royal Manchester Children'S Hospital
Manchester, England, United Kingdom
- Sir James Spence Institute of Child Health at Royal Victoria Infirmary
Newcastle upon Tyne, England, United Kingdom
- Queen'S Medical Centre
Nottingham, England, United Kingdom
- Oxford Radcliffe Hospital
Oxford, England, United Kingdom
- Children'S Hospital - Sheffield
Sheffield, England, United Kingdom
- Southampton General Hospital
Southampton, England, United Kingdom
- Royal Marsden - Surrey
Sutton, England, United Kingdom
- Royal Belfast Hospital for Sick Children
Belfast, Northern Ireland, United Kingdom
- Royal Aberdeen Children'S Hospital
Aberdeen, Scotland, United Kingdom
- Royal Hospital for Sick Children
Edinburgh, Scotland, United Kingdom
- Royal Hospital for Sick Children
Glasgow, Scotland, United Kingdom
- Childrens Hospital for Wales
Cardiff, Wales, United Kingdom
- Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Vanderbilt Children'S Hospital
Nashville, Tennessee, United States
- Texas Children'S Cancer Center and Hematology Service at Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2001
- Primary completion
- —
- Completion
- 30 Jun 2013
- Last update posted
- 10 Jan 2014
- Registered enrollment
- 376
- Registry id
- NCT00276757
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.